{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T06:06:51Z","timestamp":1746598011600},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2019,5,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Retinopathy of Prematurity (ROP) is a pathophysiologic condition of the\nretina due to abnormal proliferation of retinal vessels.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The study aimed too ascertain the importance of vascular endothelial growth factor\n(VEGF), insulin-like growth factor-1 (IGF-1), interleukin-33 (IL-33) and endocan in the diagnosis\nand follow-up of ROP.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> This prospective cohort study was conducted in the neonatal intensive care unit (NICU)\nof Health Science University, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey,\nbetween February 2017 and August 2018. Preterm infants (gestational age (GA) of \u226432 weeks and\nbirth weight of \u22641500 gr), diagnosed ROP were included in the study. VEGF, IGF-1, IL-33 and\nendocan levels were evaluated in the cord blood and in the serum before and after treatment of\ninfants in the ROP and control groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A final number of 146 infants were included in the study. During the study period, 73\ninfants were identified as the ROP group, and 73 infants were allocated as the control group. In the\nROP group, the cord blood VEGF value was higher than the control group (p &lt;0.05). However,\nIGF-1 levels in the cord blood were lower in the ROP group than control (P&lt;0.05). IL-33 and\nendocan values in the cord blood were similar in both control and ROP groups (p&gt;0.05). Although\nserum levels of IL-33, VEGF and endocan were higher before laser treatment, these biomarkers\ndecreased significantly after laser treatment (p &lt;0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>We determined that serum IL-33 and endocan levels might be suggested as sensitive\nnovel markers for the prediction of severe ROP.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207322666190325120244","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T09:02:33Z","timestamp":1553677353000},"page":"41-48","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Can IL-33 and Endocan be New Markers for Retinopathy of Prematurity?"],"prefix":"10.2174","volume":"22","author":[{"given":"Ufuk","family":"Cakir","sequence":"first","affiliation":[{"name":"Division of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuneyt","family":"Tayman","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem","family":"Yucel","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Ankara Numune Training and Research Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozdemir","family":"Ozdemir","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Zekai Tahir Burak Women's Health Training and Research Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","volume":"367","author":"Hartnett M.E.","year":"2012","unstructured":"Hartnett ME, Penn JS. N Engl J Med, Mechanisms and management of retinopathy of prematurity.,, 2012, 367,, 2515-2526,","journal-title":"N Engl J Med"},{"key":"ref=2","first-page":"91","volume":"8","author":"Liegl R.","year":"2016","unstructured":"Liegl R. Eye Brain, Hellstr\u00f6m. A.; Smith, L.E. Retinopathy of prematurity: The need for prevention.,, 2016, 8,, 91-102,","journal-title":"Eye Brain"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","volume":"56","author":"Kong L.","year":"2015","unstructured":"Kong L, Bhatt AR, Demny AB, Coats DK, Li A, Rahman EZ, Smith OE, Steinkuller PG. Invest Ophthalmol Vis Sci, Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.,, 2015, 56,, 956-961,","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","volume":"112","author":"Hellstr\u00f6m A.","year":"2003","unstructured":"Hellstr\u00f6m A, Engstr\u00f6m E, H\u00e5rd AL, Albertsson-Wikland K, Carlsson B, Niklasson A, L\u00f6fqvist C, Svensson E, Holm S, Ewald U, Holmstr\u00f6m G, Smith LE. Pediatrics, Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.,, 2003, 112,, 1016-1020,","journal-title":"Pediatrics"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","volume":"98","author":"Hellstrom A.","year":"2001","unstructured":"Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard AL, Liu JL, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LE. Proc Natl Acad Sci USA, Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity.,, 2001, 98,, 5804-5808,","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11060-014-1377-6","volume":"117","author":"Matano F.","year":"2014","unstructured":"Matano F, Yoshida D, Ishii Y, Tahara S, Teramoto A, Morita A. J Neurooncol, Endocan, a new invasion and angiogenesis marker of pituitary adenomas.,, 2014, 117,, 485-491,","journal-title":"J Neurooncol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/02713683.2014.921312","volume":"40","author":"Abu El-Asrar A.M.","year":"2015","unstructured":"Abu El-Asrar AM, Nawaz MI, De Hertogh G, Al-Kharashi AS, Van den Eynde K, Mohammad G, Geboes K. Curr Eye Res, The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.,, 2015, 40,, 321-331,","journal-title":"Curr Eye Res"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.4816","volume":"241","author":"Theodoropoulou S.","year":"2017","unstructured":"Theodoropoulou S, Copland DA, Liu J, Wu J, Gardner PJ, Ozaki E, Doyle SL, Campbell M, Dick AD. J Pathol, Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye.,, 2017, 241,, 45-56,","journal-title":"J Pathol"},{"key":"ref=9","first-page":"213","volume":"17","author":"Kliegman R.M.","year":"1987","unstructured":"Kliegman RM, Walsh MC. Curr Probl Pediatr, Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness.,, 1987, 17,, 213-288,","journal-title":"Curr Probl Pediatr"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jp.7210963","volume":"23","author":"Walsh M.C.","year":"2003","unstructured":"Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A. J Perinatol, Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia.,, 2003, 23,, 451-456,","journal-title":"J Perinatol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"Papile L.A.","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. J Pediatr, Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm.,, 1978, 92,, 529-534,","journal-title":"J Pediatr"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"","year":"2005","unstructured":". Arch Ophthalmol,  International Committee for the Classification of Retinopathy of Prematurity.The international classification of retinopathy of prematurity revisited.,, 2005, 123,, 991-999,","journal-title":"Arch Ophthalmol"},{"key":"ref=13","first-page":"SC08","volume":"9","author":"Ezz-Eldin Z.M.","year":"2015","unstructured":"Ezz-Eldin ZM, Hamid TA, Youssef MR. J Clin Diagn Res, Nabil, Hel-D. Clinical risk index for babies (CRIB II) scoring system in prediction of mortality in premature babies.,, 2015, 9,, SC08-SC11,","journal-title":"J Clin Diagn Res"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5409\/wjcp.v5.i1.35","volume":"5","author":"Shah P.K.","year":"2016","unstructured":"Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N. World J Clin Pediatr, Retinopathy of prematurity: Past, present and future.,, 2016, 5,, 35-46,","journal-title":"World J Clin Pediatr"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","volume":"106","author":"","year":"1988","unstructured":". Arch Ophthalmol, Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.,, 1988, 106,, 471-479,","journal-title":"Arch Ophthalmol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","volume":"121","author":"","year":"2003","unstructured":". Arch Ophthalmol,  Early Treatment For Retinopathy Of Prematurity Cooperative Group.Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.,, 2003, 121,, 1684-1694,","journal-title":"Arch Ophthalmol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/08820530902800314","volume":"24","author":"Heidary G.","year":"2009","unstructured":"Heidary G, Vanderveen D, Smith LE. Semin Ophthalmol, Retinopathy of prematurity: Current concepts in molecular pathogenesis.,, 2009, 24,, 77-81,","journal-title":"Semin Ophthalmol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1055\/s-0036-1586109","volume":"33","author":"Hellstr\u00f6m A.","year":"2016","unstructured":"Hellstr\u00f6m A, Ley D, Hansen-Pupp I, Hallberg B, Ramenghi LA, Lofqvist C, Smith LE, Hard AL. Am J Perinatol, Role of insulinlike growth factor 1 in fetal development and in the early postnatal life of premature infants.,, 2016, 33,, 1067-1071,","journal-title":"Am J Perinatol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ghir.2016.09.005","volume":"\u2022\u2022\u2022","author":"Hellstr\u00f6m A.","year":"2016","unstructured":"Hellstr\u00f6m A, Ley D, Hansen-Pupp I, Hallberg B, Ramenghi LA, L\u00f6fqvist C, Smith LE, H\u00e5rd AL. Growth Horm IGF Res, IGF-I in the clinics: Use in retinopathy of prematurity.,, 2016, \u2022\u2022\u2022,, 75-80,","journal-title":"Growth Horm IGF Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1651-2227.2009.01677.x","volume":"99","author":"P\u00e9rez-Mu\u00f1uzuri A.","year":"2010","unstructured":"P\u00e9rez-Mu\u00f1uzuri A, Fern\u00e1ndez-Lorenzo JR, Couce-Pico ML, Blanco-Teijeiro MJ, Fraga-Berm\u00fadez JM. Acta Paediatr, Serum levels of IGF1 are a useful predictor of retinopathy of prematurity.,, 2010, 99,, 519-525,","journal-title":"Acta Paediatr"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bjophthalmol-2016-308828","volume":"101","author":"Kandasamy Y.","year":"2017","unstructured":"Kandasamy Y, Hartley L, Rudd D, Smith R. Br J Ophthalmol, The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: A systematic review.,, 2017, 101,, 21-24,","journal-title":"Br J Ophthalmol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.yexcr.2007.01.021","volume":"313","author":"Rennel E.","year":"2007","unstructured":"Rennel E, Mellberg S, Dimberg A, Petersson L, Botling J, Ameur A, Westholm JO, Komorowski J, Lassalle P, Cross MJ, Gerwins P. Exp Cell Res, Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer.,, 2007, 313,, 1285-1294,","journal-title":"Exp Cell Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/147323001003800213","volume":"38","author":"Chen L.Y.","year":"2010","unstructured":"Chen LY, Liu X, Wang SL, Qin CY. J Int Med Res, Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion.,, 2010, 38,, 498-510,","journal-title":"J Int Med Res"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-12-1855","volume":"73","author":"Roudnicky F.","year":"2013","unstructured":"Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, Rogler A, St\u00f6hr R, Hartmann A, Provenzano M, Otto VI, Detmar M. Cancer Res, Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.,, 2013, 73,, 1097-1106,","journal-title":"Cancer Res"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1167\/iovs.17-22945","volume":"59","author":"Su T.","year":"2018","unstructured":"Su T, Zhong Y, Demetriades AM, Shen J, Sui A, Yao Y, Gao Y, Zhu Y, Shen X, Xie B. Invest Ophthalmol Vis Sci, Endocan blockade suppresses experimental ocular neovascularization in mice.,, 2018, 59,, 930-939,","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10753-011-9379-4","volume":"35","author":"Liu X.C.","year":"2012","unstructured":"Liu XC, Liu XF, Jian CX, Li CJ, He SZ. Inflammation, IL-33 is induced by amyloid-\u03b2 stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells.,, 2012, 35,, 776-784,","journal-title":"Inflammation"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/1386207321666180911090656","volume":"21","author":"Halil H.","year":"2018","unstructured":"Halil H, Tayman C, Buyuktiryaki M, Okur N, Cakir U, Serkant U. Comb Chem High Throughput Screen, Serum interleukin-33 as a biomarker in predicting neonatal sepsis in very low birth weight infants.,, 2018, 21,, 510-515,","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","volume":"114","author":"Choi Y.S.","year":"2009","unstructured":"Choi YS, Choi HJ, Min JK, Pyun BJ, Maeng YS, Park H, Kim J, Kim YM, Kwon YG. Blood, Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production.,, 2009, 114,, 3117-3126,","journal-title":"Blood"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"18106","DOI":"10.18632\/oncotarget.7635","volume":"7","author":"Milosavljevic M.Z.","year":"2016","unstructured":"Milosavljevic MZ, Jovanovic IP, Pejnovic NN, Mitrovic SL, Arsenijevic NN. Oncotarget, Simovic, Markovic, B.J.; Lukic, M.L. Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.,, 2016, 7,, 18106-18115,","journal-title":"Oncotarget"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaapos.2014.07.159","volume":"18","author":"Yalin Imamoglu,.","year":"2014","unstructured":"Yalin Imamoglu,. J AAPOS, E.; Gunay, M.; Gursoy, T.; Imamoglu, S.; Balci, Ekmekci.; Celik, G.; Karatekin, G.; Ovali, F. Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity.,, 2014, 18,, 466-470,","journal-title":"J AAPOS"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T12:01:13Z","timestamp":1560859273000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170938\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207322666190325120244","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}